Abstract

Breast cancer is the most common cancer observed in women. Although mammography is a recognized method, it remains ionizing and cannot be used routinely or in young adults, leaving up to two years between two diagnoses. Prior to validation on human subjects, this study aims to validate on phantoms the feasibility of quantifying breast density and detecting breast cancer tumors using a smart bra in young women. Six phantoms with various densities and seven phantoms with various volumes of modelized tumor were prepared and measured with a smart bra, including an electrophysiological module. There was a significant difference between the “healthy phantoms” and the “tumor phantoms” with P(Student) = 0.008 (Shapiro–Wilk p = 0.846, samples follow a normal distribution; Fisher variance test, p = 0.287). In addition, this study seems to indicate the possibility of discriminating various types of tumorous and healthy breast tissue using a smart bra, in high density breast. However, a new study on a large sample of human subjects will be required to generate new models, including resistive, capacitive, and other sensor parameters versus reference data collected from imaging.

Highlights

  • Breast cancer is the most common cancer observed in women in France, as well as in the European

  • Prior to validation on human subjects, this study aims to validate, on phantoms, the feasibility of quantifying breast density and detecting breast cancer tumors using a smart bra

  • The resistive models used indicate significant differences between the phantoms, which came from the models themselves, as well as from bias from the phantom

Read more

Summary

Introduction

Breast cancer is the most common cancer observed in women in France, as well as in the EuropeanUnion and the United States. Breast cancer is the most common cancer observed in women in France, as well as in the European. 2005, yet this disease remained as the leading cause of cancer death among women in 2012. According to the National Cancer Institute [1], there were 48,763 new cases estimated in 2012, 11,886 of which resulted in the death of the patient. Breast cancer screening mainly uses mammography (breast X-rays under different views). This technique can lead to overdiagnosis; some women are found to have precancerous lesions that have never developed. According to the National Institut of Cancer (INCa), the rate of overdiagnosis is estimated at 10% to 20%, or 2 to 3 cases of overdiagnosis for each death prevented

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.